None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? Adult patients aged 19 or older ? Chronic kidney disease 3-5 stage patients ? Patients with left ventricular congestion rate of 35% or less ?a patient who has now been inserted with a subcutaneous defibrillator for primary prevention of sudden death, as recommended by medical guideline
Exclusion criteria
Exclusion criteria: ? Those who are vulnerable to clinical research (as defined by KGCP) ? Ineligible for subcutaneous defibrillator screening ?Patients resuscitated after experiencing cardiac arrest ? Patients with a history of ventricular tachycardia ? Patients with artificial cardiac pacemakers and parenteral defibrillators ? Patients with a life expectancy of less than one year ? Patients scheduled for kidney transplantation (viii) Patients who refuse to participate in clinical research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| appropriate ventricular arrhythmia treatment frequency for subcutaneous insertion defibrillators | — |
Secondary
| Measure | Time frame |
|---|---|
| death from any cause;arrhythmic death;non arrhythmic death;incidence of inappropriate shocks;implant related complications;all kinds of hospitalization | — |
Countries
Korea, Republic of
Contacts
Keimyung University Dongsan Hospital